Distribution of toxoplasmosis among different groups of the population of the Omsk Region

Objective. Our objective was to study the prevalence of toxoplasmosis among various groups of population in the Omsk Region. Materials and methods. We analyzed statistical data and the results of our own serological tests carried out in 2000-2017. Antibodies to Toxoplasma were determined in 1,926 people (769 citizens and 1,157 villagers). The blood serum was used as the test material. For the detection of IgG and IgA antibodies to toxoplasma, we used locally produced ELISA test systems ("Vector-Best", Novosibirsk). Results. Antibodies to toxoplasmas were found in residents of all landscape areas of the Omsk Region. In the northern parts of the forest zone, 45.9 % of people had antibodies to toxoplasma; in the southern steppe zone, 64.6 % of people had those antibodies. Urban residents were infected in 17.7 % of cases. There were significant age-related differences in toxoplasma infection in the population of the Omsk Region. The maximum rates of invasion in older age groups were more than 50 % among urban residents and over 70 % in rural areas. Rates of seropositivity of rural children under 15 were 5 times higher than those in urban children. Serological markers of toxoplasmosis were detected in 52.8 % of rural women of childbearing age and in 33.9 % of urban women. Conclusion. The research results indicated the unfavorable epidemic situation for toxoplasmosis in the Omsk Region. Taking into account the risk of infection for people with immunodeficiency and pregnant women and the possibility to reactivate the invasion even in an immunocompetent organism, it is necessary to study distinctive features of the toxoplasmosis epidemic process in different areas of the Omsk Region and to develop regulatory and procedural documents on prevention of Toxoplasma infection in the population.

токсоплазмоз, паразитарная инвазия, антитела к токсоплазмам, зараженность токсоплазмами населения, toxoplasmosis, parasitic invasion, toxoplasma antibodies, infection with Toxoplasma gondii

1. Гончаров Д.Б., Габриэлян Н.И., Аббазова Е.В., Иевлева Е.С., Крупенио Т.В. Токсоплазмоз как протозойная оппортунистическая инвазия и его значение в трансплантологии // Вестник трансплантологии и искусственных органов. 2015. Т. XVII (4). С. 95-103.

2. Землянский О.А. О сероэпидемиологии токсоплазмоза у беременных женщин и новорожденных // Медицинская паразитология и паразитарные болезни. 2004. № 3. С. 40-42.

3. Калякин В.Н. Проблема природной очаговости токсоплазмоза и некоторых сходных инвазий: автореф. дис.. канд. биол. наук. М., 1972. 18 с.

4. Савилов Е.Д., Мамонтова Л.М., Астафьев В.А., Жданова С.Н. Применение статистических методов в эпидемиологическом анализе. М.: МЕДпресс-информ, 2004. 111 с.

5. Саидов М.С., Царуева Т.В., Саидова Б.М., Юсупова М.Т. Распространение токсоплазмоза у женщин детородного возраста в различных климатогеографических регионах Дагестана // Известия Дагестанского государственного педагогического университета. Естественные и точные науки. 2012. № 4 (21). С. 85-87.

6. Berghold C, Herzog SA, Jakse H, et al. Prevalence and incidence of toxoplasmosis: a retrospective analysis of mother-child examinations, Styria, Austria, 1995 to 2012. Euro Surveill. 2016; 21(33):303-17. DOI: 10.2807/1560-7917.ES.2016.21.33.30317

7. David CN, Frias ES, Szu JI, et al. GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite toxoplasma gondii. PLoS Pathogens. 2016; 12(6): e1005643. DOI: 10.1371/journal.ppat.1005643

8. Dzitko K, Gatkowska J, Dlugonska H. Toxoplasma gondii: serological recognition of reinfection. Exp Parasitol. 2006; 112(2):134-137.

9. Gargate MJ, Ferreira I, Vilares A, et al. Toxoplasma gondii sero-prevalence in the Portuguese population: comparison of three crosssectional studies spanning three decades. BMJ Open. 2016; 6(10): e011648. DOI: 10.1136/bmjopen-2016-011648

10. Jones JL, Kruszon-Moran D, Elder S, et al. Toxoplasma gondii Infection in the United States, 2011-2014. Am J Trop Med Hyg. 2018; 98(2):551-557. DOI: 10.4269/ajtmh.17-0677

11. Kim YH, Lee J, Kim YE, et al. Seroprevalence of toxoplasmosis detected by RDT in residents near the DMZ (demilitarized zone) of Cheorwon-gun, Gangwon-do, Korea. Korean J Parasitol. 2017; 55(4):385-389. DOI: 10.3347/kjp.2017.55.4.385

12. Nahouli H, El Arnaout N, Chalhoub E, et al. Seroprevalence of antiToxoplasma gondii antibodies among Lebanese pregnant women. Vector Borne Zoonotic Dis. 2017; 17(12):785-790. DOI: 10.1089/vbz.2016.2092

13. Olariu TR, Blackburn BG, Press C, et al. Role of Toxoplasma IgA as part of a reference panel for the diagnosis of acute toxoplasmosis during pregnancy. J Clin Microbiol. 2019; 57(2):e01357-18. DOI: 10.1128/JCM.01357-18

14. Peyron F, Mc Leod R, Aizenberg D, et al. Congenital Toxoplasmosis in France and the United States: one parasite, two diverging approaches. PLoS Neglected Tropical Diseases. 2017; 11(2):e000522. Published online 2017, Feb16. DOI: 10.1371/journal.pntd.00052222

15. Prusa AR, Kasper DC, Sawers L, et al. Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving. PLoS Neglected Tropical Diseases. 2017, 11(7):e0005648. DOI: 10.1371/journal.pntd.0005648

16. Ya W, Ren-Hao S. Survey of Toxoplasma gondii infection characteristics and its risk factors among healthy blood donation population in Shijiazhuang City, Hebei Province. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017; 29(3):377-379. DOI: 10.16250/j.32.1374.2016220